Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 6, 2014

View Archived Issues

Scynexis enters into global agreement with Waterstone Pharmaceutical for SCY-635

New York Blood Center and Blood Center of Wisconsin join NAITgam development consortium

Hanmi and partner Kinex report preliminary data from phase I study of Oratecan

Sunovion and ex scientia collaborate to discover novel medicines for psychiatric disorders

Novo Nordisk reports highlights of third quarter 2014

Researchers presented genetic biomarkers of cardiac dysfunction

Integra LifeSciences plans to spin off spinal surgery business

Transition Therapeutics reports data from phase II study of ELND-005 in bipolar disorder

Karus Therapeutics presents novel highly selective HDAC6 inhibitors

Phase III data presented on new levonorgestrel intrauterine contraceptive system

New URAT1 inhibitors patented by Pfizer

Singapore A*STAR reports novel Wnt pathway modulators

Esteve presents new sigma1 receptor ligands

Roche and Siena Biotech develop new BACE1 inhibitors

Sage Therapeutics presents new neuroactive steroids

University of Illinois patents new vWF secretion inhibitors

Vertex applies for U.S. and E.U. approvals of lumacaftor/ivacaftor

CYD tetravalent dengue vaccine found efficacious in phase III studies in children in Latin America

FDA approves ramucirumab in combination with paclitaxel for advanced gastric cancer

Regulatory submissions filed for mepolizumab for severe eosinophilic asthma in the U.S. and E.U.

New clinical data presented on nivolumab in the treatment of renal cell carcinoma

Advaxis submits IND application for ADXS31-142 for metastatic prostate cancer

FDA grants orphan drug designation to MM-141 for the treatment of pancreatic cancer

Isis Pharmaceuticals earns milestone payment from GSK for ISIS-GSK5-Rx

FDA approves Olysio in combination with sofosbuvir for genotype 1 chronic HCV

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...